Grifols, S.A.

€11.24As of Sun 8 Nov 2026, 12:00 UTC
BME:GRFHealthcare
Country Spain
PE (Fwd) •••
TSR 10Y CAGR (3.86%)
Div yield 2.67%
ROE 7.33%
Drug Manufacturers (General)
Beta (5Y) 1.13
PE TTM 15.65
TSR TTM 0.84%
Mkt cap €6.709B
ROIC 6.92%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€11
2.00%
(49.81%)
Hold 10|10|6|3|1
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.12
0.13
0.13
0.13
(0.18%)
17.23%
18.67%
22.55%
Revenue€M
328.2
338.8
334.0
331.7
(3.79%)
2.00%
1.60%
0.49%
Peers (US$7.533B)
Cap (US$)
PE
2.744B
40.61x
1.708B
19.00x
Capital
TTM
5Y
10Y
Leveragex
0.959
1.915
1.782
EBIT/Intx
1.514
0.266
0.271
Own earn%
(58.87)
(39.34)
(31.22)
Sh yield%
40.70
48.85
49.98
Owners
Insiders/Inst%
9.35
61.97
Short interest%
4.51
SBC / revenue%
3.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
20–30
$1 testx
—
Incr. ROIC%
4